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Abstract
Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic
disorder caused by progerin, a mutant lamin A variant. HGPS
patients display accelerated aging and die prematurely, typically
from atherosclerosis complications. Recently, we demonstrated
that progerin-driven vascular smooth muscle cell (VSMC) loss
accelerates atherosclerosis leading to premature death in
apolipoprotein E-deficient mice. However, the molecular mecha-
nism underlying this process remains unknown. Using a tran-
scriptomic approach, we identify here endoplasmic reticulum
stress (ER) and the unfolded protein responses as drivers of
VSMC death in two mouse models of HGPS exhibiting ubiquitous
and VSMC-specific progerin expression. This stress pathway was
also activated in HGPS patient-derived cells. Targeting ER stress
response with a chemical chaperone delayed medial VSMC loss
and inhibited atherosclerosis in both progeria models, and
extended lifespan in the VSMC-specific model. Our results iden-
tify a mechanism underlying cardiovascular disease in HGPS that
could be targeted in patients. Moreover, these findings may help
to understand other vascular diseases associated with VSMC
death, and provide insight into aging-dependent vascular
damage related to accumulation of unprocessed toxic forms of
lamin A.
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Introduction
Hutchinson–Gilford progeria syndrome (HGPS) is a devastating
disease with an estimated prevalence of 1 in 20 million people
(www.progeriaresearch.org). Affected children appear normal at
birth but show early onset of aging-associated symptoms, including
alopecia, reduced subcutaneous fat, osteoporosis, joint stiffness,
and dermal abnormalities (Hennekam, 2006; Gordon et al, 2007;
Merideth et al, 2008). The most important clinical manifestation of
the disease is atherosclerosis, which causes death from myocardial
infarction or stroke at an average age of 14.6 years (Ullrich &
Gordon, 2015). Progerin also provokes cardiac abnormalities
(Merideth et al, 2008; Rivera-Torres et al, 2016; Prakash et al,
2018) and defects in heart valves (Nair et al, 2004; Merideth et al,
2008; Olive et al, 2010; Hanumanthappa et al, 2011) and blood
vessels, including vascular smooth muscle cell (VSMC) loss, adven-
titial thickening, calcification, and extracellular matrix deposition
(Stehbens et al, 1999, 2001; Olive et al, 2010).
“Classic” HGPS is caused by a point mutation in the LMNA gene
(c.1824C>T;p.G608G), which activates a cryptic splice site in exon
11, leading to deletion of 150 nucleotides in the mRNA (De Sandre-
Giovannoli et al, 2003; Eriksson et al, 2003). Consequent loss of 50
amino acids near the C terminus of the precursor prelamin A protein
affects its post-translational modifications, resulting in the produc-
tion of a permanently farnesylated mutant protein called progerin.
Progerin alters many of the cellular functions normally regulated by
lamin A, causing abnormal localization of nuclear envelope
proteins, impaired chromatin organization, DNA damage and
genome instability, mitochondrial dysfunction, oxidative stress,
altered gene transcription and signal transduction, among others
(Gordon et al, 2014b; Vidak & Foisner, 2016; Dorado & Andres,
2017). However, only a few studies have investigated the molecular
alterations caused by progerin accumulation in VSMCs (Zhang et al,
2011, 2014; Villa-Bellosta et al, 2013; Hamczyk et al, 2018a), and
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none analyzed it in the context of atherosclerosis, the main death-
causing symptom of HGPS, due to lack of adequate animal models.
Recently, we have generated an HGPS-like mouse model of ubiqui-
tous progerin expression that reproduces the main features of
human HGPS, including VSMC loss in the aortic media, adventitial
thickening, accelerated atherosclerosis, and shortened lifespan
(Hamczyk et al, 2018b). Moreover, we have shown that limiting
progerin expression to VSMCs is sufficient to cause the loss of these
cells in the aorta and accelerate atherosclerosis and death, demon-
strating a key role of VSMCs in the pathogenesis of HGPS (Hamczyk
et al, 2018b). The aim of this study was to identify molecular mech-
anisms underlying progerin-induced VSMC loss, the principal driver
of premature atherosclerosis and death in HGPS.
Results
To identify pathways underlying progerin-induced VSMC death,
we conducted a transcriptomic analysis of progerin-expressing
aortas. To this end, we used two mouse models of HGPS, with
progerin expressed either ubiquitously (Apoe/LmnaG609G/G609G)
or restricted to VSMCs (Apoe/LmnaLCS/LCSSM22aCre), which
fully recapitulate the vascular phenotype observed in HGPS
patients (Olive et al, 2010; Hamczyk et al, 2018b). To identify
drivers of disease rather than secondary changes, we sought to
collect arteries before the onset of evident disease. Since both
substantial atherosclerosis and overt aortic structure alterations
are found in normal chow-fed 16-week-old mice, but absent in
normal chow-fed 8-week-old mice of both genotypes (Hamczyk
et al, 2018b), we collected aortas at 8 weeks of age. To specifi-
cally detect molecular alterations in VSMC, which appear to be a
major progerin target, we digested aortas with collagenase to
separate fibroblast-containing adventitia from the VSMC-rich
media (Fig 1A). We collected four pooled samples per genotype
(Apoe/LmnaG609G/G609G and Apoe/LmnaLCS/LCSSM22aCre mice
and their corresponding littermate controls Apoe/Lmna+/+ and
Apoe/LmnaLCS/LCS, respectively), which showed the expected
progerin and lamin A expression as assessed by PCR (Fig 1B).
Differential expression analysis of RNA sequencing data revealed
776 significantly altered genes in the ubiquitous progeroid model
and 931 altered genes in the VSMC-specific model (Fig 1C, Datasets
EV1 and EV2). Of these differentially regulated genes, 240 were
common to both comparisons (Fig 1C, Dataset EV3) and exhibited
high correlation (R2  0.8, Fig 1D). Analysis of the two controls
revealed 176 genes differentially expressed between Apoe/
LmnaLCS/LCS aorta (expressing lamin C only) and Apoe/Lmna+/+
aorta (expressing wild-type lamin A/C; Dataset EV4). However, there
was barely any overlap between the gene sets affected by
progerin production in Apoe/LmnaG609G/G609G and Apoe/
LmnaLCS/LCSSM22aCre mice and those influenced by the lack of
lamin A in Apoe/LmnaLCS/LCS mice (Fig 1C). Likewise, we found
no overlap in the main pathways affected by progerin expression
(Fig EV1A and B) and lack of lamin A (Fig EV1C).
Comparison analysis identified four pathways that were signifi-
cantly altered in medial aorta in both the ubiquitous and the VSMC-
specific progerin-expressing models: fibrosis, nuclear factor erythroid
2-like 2 (NRF2)-mediated oxidative stress, endoplasmic reticulum
(ER) stress response, and unfolded protein response (UPR; Fig 1E,
Canonical pathways). We also examined the predicted activation
status of upstream regulators based on the expression of their target
genes. This analysis revealed that the most differentially regulated
factors belong to the ER stress response and ER stress-related UPR.
These factors include X-box-binding protein 1 (XBP1), activating
transcription factor 4 (ATF4; also known as cyclic AMP-dependent
transcription factor ATF-4), eukaryotic translation initiation factor 2-
alpha kinase 3 (EIF2AK3; also known as protein kinase RNA-like ER
kinase; PERK), and DNA damage-inducible transcript 3 protein
(DDIT3; also known as C/EBP-homologous protein, CHOP; Fig 1E,
Upstream regulators, genes in each ER stress-related upstream regula-
tor network are shown in Fig EV2A–F). Further overrepresentation
test for gene ontology (GO) cellular compartment of 240 genes shared
between ubiquitous and VSMC-specific progeroid models showed
higher than 10-fold enrichment for sarcoplasmic reticulum
(GO:0016529) and sarcoplasm (GO:0016528; Table EV1).
To validate the RNA sequencing results, we performed quantita-
tive real-time PCR on selected ER stress response and UPR genes
that were significantly upregulated in aortic media from 8-week-old
mice in both progeria models (Fig 2A; see also schemes in
Appendix Fig S1 showing genes within ER stress/UPR pathway
significantly altered in each model). This analysis confirmed
progerin-induced upregulation of Calr, Ddit3, Dnajb9, Hspa5,
Hsp90b1, and Pdia4 in VSMC-rich aortic media in both models
(Fig 2B and C). We next used quantitative real-time PCR to analyze
immortalized HGPS patient-derived cells. A wide range of ER stress-
related genes, such as HSP90B1, HSPA5, CALR, and DNAJC3, and
the bona fide UPR genes DDIT3, ATF4, EIF2AK3, ERN1, PPP1R15A,
and the spliced form of XBP1 were upregulated in HGPS patient cells
(Fig 2D). We also assessed whether progerin activates the ER stress
response and the UPR in other organs of our progeroid mouse
models. Consistent with the ubiquity of progerin expression in
Apoe/LmnaG609G/G609G mice, induction of ER stress response and
the UPR was noted in some organs of these animals, with kidney
being the most affected organ and liver the least (Fig 2E). As antici-
pated, no activation of this stress pathway was detected in kidney,
liver, spleen, or heart from Apoe/LmnaLCS/LCSSM22aCre mice,
consistent with the VSMC-specificity of the model (Fig 2F). The
state of ER stress in VSMCs in the aorta of both progeroid mouse
models was further confirmed by immunostaining against ER chap-
erone binding-immunoglobulin protein (BiP, also known as 78 kDa
glucose-regulated protein, GRP78; product of Hspa5 gene), calretic-
ulin (product of Calr gene), and protein disulfide isomerase (PDI;
product of P4hb gene; Fig 3A and B). Quantitative analysis revealed
higher level of these proteins in the aorta of both progeroid mouse
models compared with their respective controls (Fig 3C and D).
Our RNA sequencing results strongly suggested that progerin-
induced ER stress response and UPR might underlie VSMC death
and enhance atherosclerosis in the ubiquitous and VSMC-specific
progeria mice. We therefore examined the potential benefits of
tauroursodeoxycholic acid (TUDCA), a chemical chaperone that
augments the capacity of cells to sustain ER stress and protects
from apoptosis (Xie et al, 2002; Rivard et al, 2007; Uppala et al,
2017). One-week TUDCA treatment of 8-week-old Apoe/
LmnaLCS/LCSSM22aCre mice slightly increased in medial aorta the
mRNA levels of Pdia4 (coding for a protein disulfide isomerase)
and Hsp90b1 (coding for a chaperone; Fig EV3), suggesting mild
enhancement of protein folding capacity. Moreover, it markedly
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* Significant in both comparisons after applying Benjamini-Hochberg correction
Figure 1. Progerin expression in vascular smooth muscle cell (VSMC)-rich aortic media activates endoplasmic reticulum (ER) stress and unfolded protein
response (UPR).
A Sample preparation for RNA sequencing (RNAseq).
B PCR confirmation of proper expression of lamin A and progerin mRNA in pooled medial aortas used for RNAseq. Arbp was used as endogenous control.
C Bioinformatic analysis detected 776 differentially expressed genes in medial aortas from Apoe/LmnaG609G/G609G mice with ubiquitous progerin expression compared
with Apoe/Lmna+/+ control mice expressing wild-type lamin A/C and 931 genes in medial aortas from Apoe/LmnaLCS/LCSSM22aCre mice with VSMC-specific
progerin expression compared with Apoe/LmnaLCS/LCS control mice expressing lamin C only. There were 176 genes differentially expressed between the two control
groups. The Venn diagram shows the overlap between sets of deferentially expressed genes identified in each of the three comparisons (n = 4 pooled medial aortas
for each genotype).
D Correlation between base-2 logarithms of fold change calculated for the 240 genes shared between the comparisons “ubiquitous progerin versus wild-type lamin
A/C” and “VSMC-specific progerin versus lamin C only”.
E RNAseq results were analyzed using Ingenuity Pathway Analysis: (left) canonical pathway heatmap, showing processes affected by progerin expression in VSMC-rich
medial aortas. Asterisk (*) indicates pathways which are significantly changed in both comparisons after applying the Benjamini–Hochberg correction for multiple
testing; (right) upstream regulator heatmap, showing predicted activation states of transcriptional regulators (black boxes indicate key molecules involved in ER stress
and UPR regulation). Genes in each upstream regulator network are shown in the Fig EV2.
Source data are available online for this figure.
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decreased the expression of Ddit3 gene coding for DDIT3
(Fig EV3), a pro-apoptotic transcription factor of the UPR machin-
ery, indicating that TUDCA helps to resist ER stress-induced death
in VSMCs.
After confirming that prolonged TUDCA administration did not
trigger any deleterious side effects (Appendix Fig S2), we evaluated
its effectiveness in ameliorating vascular disease in high-fat diet-fed
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Figure 2.
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treatment alleviated aortic VSMC loss (Fig 4A and B), adventitial
thickening (Fig 4C and D), and inhibited atherosclerosis (Fig 4E
and F) in both Apoe/LmnaG609G/G609G and Apoe/LmnaLCS/LCS
SM22aCre mice. Atheromas of TUDCA-treated progeroid animals
showed reduced necrotic core size and increased VSMC content
(Table EV2), indicating an amelioration of the vulnerable plaque
phenotype reported previously in these mice (Hamczyk et al,
2018b). We next assessed the effect of a sustained TUDCA treatment
on survival in normal chow-fed progeroid mice. TUDCA prolonged
the median lifespan of Apoe/LmnaLCS/LCSSM22aCre mice by
38% (median survival: 64.15 weeks in TUDCA-treated versus
46.45 weeks in untreated mice), without significantly affecting the
survival of Apoe/LmnaG609G/G609G mice (Fig 4G).
Discussion
Given the importance of VSMCs in progerin-driven cardiovascular
disease (Stehbens et al, 2001; Olive et al, 2010; Hamczyk et al,
2018b), we sought to identify mechanisms underlying VSMC death
and enhanced atherosclerosis in HGPS, which seem to be indepen-
dent of elevated cholesterol levels in the blood (Gordon et al, 2005;
Hamczyk et al, 2018b). Previous in vitro and in vivo studies identi-
fied numerous pathways potentially contributing to HGPS (Strand-
gren et al, 2017). Most of them are mutually dependent, making it
difficult to distinguish primary from secondary mechanisms. Our
RNAseq analysis of pre-disease aortic medial cells from the ubiqui-
tous and VSMC-specific progeria models identified for the first time
the ER stress response and the related UPR as potential driver mech-
anisms of VSMC death and the subsequent atherosclerosis in proge-
ria. ER stress activation in other tissues of progeroid mice was
variable. This variability might be at least in part attributed to dif-
ferent levels of lamin A (and thus progerin) expression associated
with differences in tissue stiffness, with lower expression in softer
tissues (Swift et al, 2013; Swift & Discher, 2014). Moreover, distinct
organs and tissues may have different thresholds for tolerating
misfolded protein load and therefore be more prone or resistant to
ER stress.
Under ER stress conditions, cells activate UPR to restore home-
ostasis, but death occurs when stress cannot be resolved. Due to
constant crosstalk between stress pathways, ER stress can lead to
activation of other stress responses. For example, it can sensitize
cells to DNA damage-induced apoptosis (Mlynarczyk & Fahraeus,
2014), providing a possible link between our findings and previous
studies showing increased DNA damage in HGPS cells (Liu et al,
2013). In accordance with recent studies in HGPS fibroblasts that
identified the NRF2 pathway as a major progerin target (Kubben
et al, 2016), our RNAseq analysis detected NRF2-mediated oxidative
stress response as one of the main pathways affected by progerin
expression in VSMCs. Oxidative stress induced by NRF2 is
connected with ER stress through the protein kinase EIF2AK3,
which phosphorylates the transcription factor NRF2 in response to
ER stress (Cullinan et al, 2003). Moreover, ER stress is associated
with inflammation, autophagy, and mitochondrial dysfunction
(Senft & Ronai, 2015), processes affected in progeria (Marino et al,
2008; Osorio et al, 2012; Rivera-Torres et al, 2013). Our results
identify an upstream mechanism of great importance in VSMCs,
which may link various stress pathways previously described in
progeria. Future studies are warranted to assess whether progerin
induces ER stress directly or indirectly, and to identify the exact
mechanism of ER stress/UPR-related VSMC death triggered by
progerin.
Our work also demonstrates that treatment with TUDCA, previ-
ously proven to efficiently alleviate ER stress in experimental
diabetes (Ozcan et al, 2006), aortic valve calcification (Cai et al,
2013), and cardiac disease (Rivard et al, 2007; Rani et al, 2017),
markedly ameliorated vascular pathology in the fat-fed mouse
models with ubiquitous and VSMC-specific progerin expression
(Apoe/LmnaG609G/G609G and Apoe/LmnaLCS/LCSSM22aCre mice,
respectively). However, TUDCA did not prolong lifespan in Apoe/
LmnaG609G/G609G mice with ubiquitous progerin expression. This is
in accordance with previous observations that, unlike HGPS
patients, these mutant mice apparently die from atherosclerosis-
independent causes, possibly arrhythmias, starvation, and cachexia
(Hamczyk et al, 2018b; Kreienkamp et al, 2018). In contrast to
Apoe/LmnaG609G/G609G mice, Apoe/LmnaLCS/LCSSM22aCre mice
most likely die from atherosclerosis-related causes (Hamczyk et al,
2018b). In this setting, we have shown here that prevention of
atherosclerosis by TUDCA was also associated with a significant
increase of lifespan in Apoe/LmnaLCS/LCSSM22aCre mice.
At the molecular level, 1-week in vivo TUDCA treatment caused
a slight increase in the expression of some genes related to protein
folding and modification in progerin-expressing medial aortas.
Importantly, TUDCA diminished the mRNA levels of pro-apoptotic
Ddit3, consistent with the known cytoprotective properties of this
compound (Xie et al, 2002; Rivard et al, 2007; Gavin et al, 2016;
Uppala et al, 2017). Overall, these results suggest that TUDCA simu-
lates the pro-survival UPR and attenuates the pro-apoptotic UPR;
however, the exact molecular mechanism of action of TUDCA in
progerin-expressing cells remains to be explored in further details.
◀ Figure 2. Endoplasmic reticulum (ER) stress and unfolded protein response (UPR) activation in progerin-expressing medial aortas and in Hutchinson–Gilfordprogeria syndrome (HGPS) patient-derived cells.
A Six ER stress/UPR pathway genes selected for quantitative real-time PCR validation from among those detected as differentially expressed in RNAseq in both the
ubiquitous and the vascular smooth muscle cell (VSMC)-specific models.
B, C mRNA levels of the selected genes in medial aortas obtained from 8-week-old Apoe/LmnaG609G/G609G mice (B) and Apoe/LmnaLCS/LCSSM22aCre mice (C) and their
corresponding controls. Hprt and Gusb were used for normalization (n = 4 pools of medial aortas for each genotype).
D Quantification of mRNA levels of several ER stress and UPR genes in patient-derived immortalized human HGPS fibroblasts relative to healthy control. GAPDH was
used for normalization and PBGD served as a negative control (n = 3 cultures for each group).
E, F mRNA levels of the selected genes in organs from 8-week-old Apoe/LmnaG609G/G609G mice (E) and Apoe/LmnaLCS/LCSSM22aCre mice (F) and their corresponding
controls. Hprt and Gusb were used for normalization (n = 4 mice for each genotype).
Data information: In (B–F), data are presented as mean  SEM. Statistical differences were analyzed by one-tailed unpaired t-test in (B, C), one-tailed one-sample t-test
in (D), and by two-tailed unpaired t-test in (E, F). #P < 0.061, *P < 0.05, **P < 0.01, ***P < 0.001. The exact P-values are shown in Appendix Table S1.
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The chemical chaperone TUDCA, a low-abundance bile acid in
humans (Bentayeb et al, 2008), has been successfully used to treat
cholestatic liver disease in humans (Crosignani et al, 1996; Larghi
et al, 1997). Various studies reported no adverse effects of TUDCA
treatment (daily doses from 500 to 1,750 mg per person) in obese,
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Apoe-/- Lmna+/+ Apoe-/- LmnaG609G/G609G Apoe-/- LmnaLCS/LCS Apoe-/- LmnaLCS/LCS SM22αCre
Figure 3. Activation of endoplasmic reticulum stress in medial aortas of Apoe/LmnaG609G/G609G and Apoe/LmnaLCS/LCSSM22aCre mice.
A, B Representative immunofluorescence images of aortas from 8-week-old Apoe/LmnaG609G/G609G (A) and Apoe/LmnaLCS/LCSSM22aCre (B) mice and their
corresponding controls stained with anti-a-smooth muscle actin (SMA) antibody (red), endoplasmic reticulum chaperone binding-immunoglobulin protein (BiP,
white, upper panel), protein disulfide isomerase (PDI, white, middle panel), and calreticulin (white, bottom panel). Arrowheads indicate BiP-positive cells. Scale bar:
50 lm. L, lumen; M, media; A, adventitia.
C, D Graphs show quantification of BiP, PDI, and calreticulin protein expression in medial aortas from 8-week-old Apoe/LmnaG609G/G609G (C) and Apoe/LmnaLCS/LCS
SM22aCre (D) mice relative to control mice (n = 6–9 mice for each genotype; aortic regions analyzed: aortic arch).
Data information: In (C, D), data are mean  SEM. Statistical differences were analyzed by one-tailed unpaired t-test with Welch’s correction.
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et al, 1996; Angelico et al, 1999; Invernizzi et al, 1999; Kars et al,
2010). In general, chemical chaperones show exceptional in vivo
safety, and some of them have been approved for clinical use by the
U.S. Food and Drug Administration, for example, 4-phenylbutyrate
for urea cycle disorders (Maestri et al, 1996; Burlina et al, 2001)
and ursodeoxycholic acid for primary biliary cirrhosis (Heathcote
et al, 1994; Lindor et al, 1994; Poupon et al, 1999). Importantly,
chemical chaperones have been used successfully in children
(Maestri et al, 1996; Burlina et al, 2001). Since the existing thera-
pies for HGPS show only moderate therapeutic clinical benefits
(Gordon et al, 2012, 2014a, 2016), our work suggests that the poten-
tial of chemical chaperone treatment to ameliorate atherosclerosis
and associated cardiovascular events should be explored in children
with HGPS. The use of a combination of drugs targeting different
pathways may be an effective therapeutic strategy until approaches
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Materials and Methods
Study approval
Animal experimental procedures followed the EU Directive 2010/
63EU and Recommendation 2007/526/EC, enforced in Spanish law
under Real Decreto 53/2013. Animal protocols were approved by
the local ethics committees and the Animal Protection Area of the
Comunidad Autónoma de Madrid (PROEX167/16).
Mice
All mice were housed in specific pathogen-free facility in individually
ventilated cages (maximum of 5 animals per cage) with 12-h light/
12-h dark cycle at a temperature of 22  2°C, 50% of relative
humidity (range of 45–60%). Mice had ad libitum access to water
and food (5K67, LabDiet and D184, SAFE). Experimental mice
used in this study were C57BL/6J males with ubiquitous
(Apoe/LmnaG609G/G609G) and VSMC-specific (Apoe/LmnaLCS/LCS
SM22aCre) progerin expression and their littermate controls with
lamin A/C (Apoe/Lmna+/+) and lamin C only (Apoe/LmnaLCS/LCS)
expression, respectively (Osorio et al, 2011; Hamczyk et al, 2018b).
LmnaLCS/LCS mice used for the generation of VSMC-specific
progeroid model show slightly increased weight and survival
compared to wild-type controls (Lopez-Mejia et al, 2014). The
LmnaLCS (Lamin C-STOP) allele consists of a modified Lmna gene
in which a neomycin resistance gene flanked with two loxP
sequences was introduced after exon 10 to abolish lamin A produc-
tion. Additionally, an HGPS-equivalent point mutation (c.1827C>T;
p.G609G) was inserted in exon 11. Excision of the neomycin resis-
tance cassette in the presence of Cre recombinase enables progerin
production (as well as lamin C and some residual lamin A). The
specificity of Apoe/LmnaLCS/LCSSM22aCre mouse model, which
expresses Cre (and hence progerin) under a SM22a (Tagln, trans-
gelin) promoter, was assessed previously in the aorta by immuno-
histochemistry and in the heart, spleen, kidney, and liver by PCR
(Hamczyk et al, 2018b). In the current manuscript, we examined
by immunofluorescence the presence of progerin in embryonic tissues
and in adult kidney and intestine of Apoe/LmnaLCS/LCSSM22aCre
mice (Appendix Figs S3–S8). At 11.5 days post coitum (dpc),
Apoe/LmnaLCS/LCSSM22aCre embryo had undetectable progerin
expression in the aorta (Appendix Fig S3A), intestine (Appendix Fig
S4A) and kidney (Appendix Fig S5A), and very low level of expres-
sion was observed in some cells of the heart (Appendix Fig S6A). At
15.5 dpc, progerin expression in Apoe/LmnaLCS/LCSSM22aCre
embryos was detected principally in the aorta (Appendix Fig S3B)
and, to a lesser extent, in the heart (predominantly evident in the
valves, some expression was also observed in the ventricle wall,
Appendix Fig S6B). Progerin expression in the intestine of Apoe/
LmnaLCS/LCSSM22aCre embryos at 15.5 dpc was limited to a few
cells in the muscularis, but was undetectable in the mucosa
(Appendix Fig S4B). Expression of progerin in the kidney of Apoe/
LmnaLCS/LCSSM22aCre embryos at 15.5 dpc was undetectable or
extremely low (Appendix Fig S5B). Kidneys of adult Apoe/
LmnaLCS/LCSSM22aCre mice showed progerin expression predomi-
nantly restricted to arteries and arterioles, with low expression of
the mutant protein in sparse cells outside the vessel wall
(Appendix Fig S7). Progerin expression in the intestine of adult
Apoe/LmnaLCS/LCSSM22aCre mice was detected principally in the
muscularis externa (Appendix Fig S8A and C), but smooth muscle
cell loss was not observed in any of the regions analyzed in both
the circular and the longitudinal muscle (Appendix Fig S8B and D).
Sample size for animal studies was estimated based on our previous
experience and mouse availability.
Embryos
Apoe/LmnaLCS/LCSSM22aCre and Apoe/LmnaLCS/LCS mouse
embryos were collected at 11.5 and 15.5 dpc. Day 0 of gestation
was identified by the detection of the vaginal plug in the morn-
ing after overnight mating. Embryos were microdissected under
a surgical stereoscopic microscope, and exsanguinated in phos-
phate-buffered saline (PBS) and heparin.
Sample collection and preparation for RNA sequencing
Eight-week-old mice (Apoe/LmnaG609G/G609G, Apoe/Lmna+/+,
Apoe/LmnaLCS/LCSSM22aCre, and Apoe/LmnaLCS/LCS) were
sacrificed by CO2 inhalation, and thoracic aortas were extracted,
cleaned of fatty tissue, and digested with 2 mg/ml collagenase
◀ Figure 4. Tauroursodeoxycholic acid (TUDCA) treatment alleviates vascular phenotype in progeria mouse models and extends lifespan in Apoe/LmnaLCS/LCSSM22aCre mice.
Mice were injected 3 times a week with TUDCA or phosphate-buffered saline (PBS), starting at 6 weeks of age for Apoe/Lmna+/+ and Apoe/LmnaG609G/G609G mice and at
8 weeks of age for Apoe/LmnaLCS/LCS and Apoe/LmnaLCS/LCSSM22aCremice. In (A–F), mice were fed a high-fat diet for 8 weeks starting at 8 weeks of age and sacrificed at
16 weeks of age. In (G), mice were fed normal chow.
A, B Representative immunofluorescence images of aortas stained with anti-a-smooth muscle actin (SMA) antibody (red) and Hoechst 33342 (blue). Graphs show
quantification of vascular smooth muscle cell (VSMC) content in the media as either % of SMA-positive area (top) or nucleus count (bottom) (n = 6 mice for each
group in A; n = 4–5 mice for each group in B; aortic regions analyzed: aortic arch and thoracic aorta). Scale bar: 50 lm. m, media; a, adventitia.
C, D Representative histology sections of hematoxylin & eosin (H&E)-stained aortas. Graphs show quantification of adventitia-to-media thickness ratio (n = 6 mice for
each group in C; n = 4–5 mice for each group in D; aortic regions analyzed: aortic arch and thoracic aorta). Scale bar: 100 lm. m, media; a, adventitia.
E, F Representative images of thoracic aortas stained with Oil Red O and quantification of atherosclerosis burden in TUDCA-treated and untreated (PBS) fat-fed mice of
the indicated genotypes (n = 7–8 mice for each group in E; n = 6–8 mice for each group in F).
G Kaplan–Meier survival curves of TUDCA-treated and untreated (PBS) mice of the indicated genotypes (n = 7–8 Apoe/LmnaG609G/G609G mice for each group; n = 16
Apoe/LmnaLCS/LCSSM22aCre mice for each group); P < 0.0001 for TUDCA-treated vs untreated Apoe/LmnaLCS/LCSSM22aCre mice (median survival: 64.15 vs
46.45 weeks, respectively).
Data information: Data in (A–F), are mean  SEM. Statistical differences were analyzed by one-tailed unpaired t-test in (A–D), one-way ANOVA with Tukey0s post hoc test
in (E, F), and by log-rank test in (G). **P < 0.01, ***P < 0.001.
Source data are available online for this figure.
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(CLS-2, Worthington) for 10 min at 37°C to separate medial and
adventitial tissue. Medial aortas from 3 to 5 mice of the same geno-
type were pooled and snap frozen. Samples were disrupted using
TissueLyser (Qiagen), and total RNA was isolated with QIAzol (Qia-
gen). RNA integrity was confirmed by RNA electrophoresis and with
an Agilent 2100 Bioanalyzer.
Library preparation and RNA sequencing
Total RNA (500 ng) was used to prepare barcoded RNA sequencing
libraries using the TruSeq RNA sample preparation kit v2 (Illumina)
as described before (Villa-Bellosta et al, 2017). In brief, poly-A+
RNA was isolated using poly-T oligo-attached magnetic beads
followed by fragmentation and first and second cDNA strand
synthesis. cDNA 30 ends were adenylated and the adapters were
ligated. After PCR library amplification, its size was tested using the
Agilent 2100 Bioanalyzer DNA 1000 chip and concentration was
measured in a Qubit fluorometer (Life Technologies). Libraries were
sequenced on a HiSeq2500 sequencer (Illumina), 60-base single
reads were generated. FastQ files for each sample were created
using CASAVA v1.8 (Illumina). Next-generation sequencing was
performed by the CNIC Genomics Unit.
Differential expression analysis
Sequencing reads were pre-processed by means of a pipeline that
used FastQC (Andrews, 2010) to assess read quality, and Cutadapt
(Martin, 2011) to trim sequencing reads eliminating Illumina adap-
tor remains, and to discard reads that were shorter than 30 base
pairs. The number of reads obtained per sample was in the range of
8–14 million. The resulting reads were mapped against the mouse
transcriptome (GRCm38, release 76; aug2014 archive) and quanti-
fied using RSEM v1.17 (Li & Dewey, 2011). The percentage of
aligned reads was in the range of 79–82%. Data were then
processed with a differential expression analysis pipeline that used
the Bioconductor package EdgeR (Robinson et al, 2010) for normal-
ization and differential expression testing. Only genes with at least 1
count per million in at least four samples (13,664 genes) were
considered for statistical analysis. Three comparisons were made to
identify differentially expressed genes in our models: Apoe/
LmnaG609G/G609G versus Apoe/Lmna+/+ (Dataset EV1); Apoe/
LmnaLCS/LCSSM22aCre versus Apoe/LmnaLCS/LCS (Dataset EV2);
and Apoe/LmnaLCS/LCS versus Apoe/Lmna+/+ (Dataset EV4).
The list of 240 genes shared between Datasets EV1 and EV2 was
extracted (Dataset EV3) and logFC (base-2 logarithms of fold
change) for those genes were plotted against each other using
Microsoft Excel to check for correlation. Differential expression
analysis was performed in the CNIC Bioinformatics Unit. Area-
proportional Venn diagrams were generated using BioVenn (Hulsen
et al, 2008) to visualize the overlap between data sets. Overrepre-
sentation test for GO cellular compartment was performed using
PANTHER (www.pantherdb.org, release 2017-04-13; GO Ontology
database released 2017-08-14).
Pathway analysis
Ingenuity Pathway Analysis (IPA, Qiagen) was used for more
comprehensive transcriptomic data analysis. Briefly, core analyses
were performed for the three comparisons in order to visualize path-
ways altered by progerin expression as well as by the lack of lamin
A. Benjamini–Hochberg correction of the P-value was applied to
extract the significantly altered pathways and stacked bar charts
were exported. A comparison analysis was performed to compare
results obtained with ubiquitous and VSMC-specific progeroid
models. Heatmaps showing canonical pathways and upstream regu-
lators were exported. For more detailed information about IPA tools
(Global Canonical Pathways, Upstream regulators, and Comparative
analysis), see www.qiagenbioinformatics.com/products/ingenuity-
pathway-analysis.
mRNA isolation and reverse transcription for animal studies
Tissues were homogenized using TissueLyser (Qiagen), and
total RNA was extracted with QIAzol reagent (Qiagen). RNA
was dissolved in RNase-free water, and concentration was
quantified using a NanoDrop spectrophotometer (Wilmington,
USA). RNA (1–2 lg) was reverse-transcribed into cDNA using
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems).
PCR detection of lamin A and progerin
Discrimination between lamin A and progerin mRNAs was
performed according to a protocol modified from Yang et al (2008).
Briefly, cDNA (100 ng) was amplified by PCR using DNA poly-
merase (Biotools, Spain) and PCR products were separated on a 2%
agarose gel with ethidium bromide. Images were taken using a
Molecular Imager Gel Doc XR+ System (Bio-Rad) with Image Lab
software (Bio-Rad).
Quantitative real-time PCR for animal studies
Quantitative real-time PCR was performed using Power SYBR Green
PCR Master Mix (Applied Biosystems). PCR mixes were loaded on
384-well plates (Applied Biosystems) and run on a 7900-FAST-384
thermal cycler (Applied Biosystems). All the values were normal-
ized to the internal controls beta glucuronidase (Gusb) and hypox-
anthine guanine phosphoribosyl transferase (Hprt) genes. All
reactions were performed in triplicate. Primers used in this study
are shown in Appendix Table S2.
Cell culture
Immortalized cell lines were obtained by retroviral introduction
of TERT, V12-HRAS, and SV40 large and small T antigens in
primary dermal fibroblasts from HGPS patient (NIA Aging Cell
Culture Repository, Coriell Institute, AG06297) and age-matched
control wild-type individual (CRL-1474 from ATCC) as previ-
ously described (Hahn et al, 1999; Scaffidi & Misteli, 2011;
Fernandez et al, 2014). Typical passage number of primary cells
before transformation was between 10 and 15, and further
experiments in immortalized cells were performed within the
first 15 passages after transformation. Cells were grown in
MEM containing 15% fetal bovine serum, 2 mmol/l L-glutamine,
100 U/ml penicillin, and 100 lg/ml streptomycin, at 37°C in
5% CO2.
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RNA extraction and reverse transcription for cell studies
RNA was extracted from cells using the RNeasy Mini Kit (Qiagen)
according to the manufacturer instructions. RNA (1 lg) was reverse-
transcribed into cDNA using iScript cDNA synthesis kit (Bio-Rad) for
20 min at 46°C, after a denaturation step of 1 min at 95°C.
Quantitative real-time PCR for cell studies
Quantitative real-time PCR was performed using iQ SYBR Green
Supermix (Bio-Rad) in a C1000 Touch Thermal Cycler (Bio-Rad).
Reaction conditions were as follows: 3 min at 95°C, 1 cycle; 20 s at
95°C, 30 s at 61°C, 40 cycles. All the values were normalized to
the internal control glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene. All reactions were performed in triplicate. Primer
combinations are indicated in Appendix Table S3.
Chemical chaperone treatment in vivo
TUDCA (580549, Calbiochem) was dissolved in PBS and passed
through a 0.22-lm filter. After genotyping, mice were randomized into
treatment and control groups (equal or similar number of animals
from each litter was assigned to each group). TUDCA (400 mg/kg) or
PBS was administered intraperitoneally 3 times a week or for 7 consec-
utive days, depending on the experiment. Treatment started at
6 weeks of age in the case of Apoe/LmnaG609G/G609G mice (and
control Apoe/Lmna+/+ mice) or 8 weeks of age in the case of
Apoe/LmnaLCS/LCSSM22aCre mice (and control Apoe/LmnaLCS/LCS
mice). Treatment ended at 9 weeks of age for gene expression studies,
and at 16 weeks of age for high-fat diet experiments. In case of long-
evity studies, treatment was maintained until animal’s death.
For atherosclerosis experiments, animals were fed high-fat diet
(10.7% total fat, 0.75% cholesterol, S9167-E010, SSNIFF, Germany)
for 8 weeks starting at 8 weeks of age, and sacrificed at 16 weeks of
age after overnight fasting.
For longevity experiments, normal chow-fed mice were weighted
once a week and inspected for health issues and survival three times
a week starting at 6 or 8 weeks of age depending on genotype. One
animal was excluded from the study due to health issues associated
with injection. Animals that met humane endpoint criteria were
sacrificed and the deaths recorded.
Quantification of atherosclerosis burden
Aortic atherosclerosis was quantified as previously described (Ham-
czyk et al, 2018b). Briefly, mouse aortas were fixed with 4%
formaldehyde in PBS, cleaned of fatty tissue, and stained with 0.2%
Oil Red O (ORO, O0625, Sigma). The thoracic aorta was cut open
longitudinally and pinned out flat for planimetric analysis. Images
were taken with a digital camera (OLYMPUS UC30) mounted on a
stereo microscope (OLYMPUS SZX3). Lesion area was quantified as
a percentage of ORO-positive aortic surface using SigmaScan Pro 5
software (Systat Software Inc) by a researcher blinded to genotype.
Immunofluorescence and histology
Organs and embryos were fixed with 4% formaldehyde in PBS
and either included in Tissue-Tek OCT compound (SAKURA,
Netherlands) or paraffin. For OCT-embedded specimens (aortic
arch), 8-lM sections were prepared and stained with hematoxylin-
eosin (H&E). For immunofluorescence, sections were incubated for
1 h at room temperature (RT) in blocking and permeabilizing solu-
tion: PBS containing 0.3% Triton X-100 (9002-93-1, Sigma), 5%
normal goat serum (005-000-001, Jackson ImmunoResearch), and
5% bovine serum albumin (BSA, A7906, Sigma). Sections were then
incubated overnight at 4°C with anti-BiP (3177, Cell Signaling,
1:100), anti-PDI (3501, Cell Signaling, 1:100), and anti-calreticulin
(ab92516, abcam, 1:250) antibodies diluted in PBS containing 0.3%
Triton X-100 and 2.5% normal goat serum. Samples were incubated
for 2 h at RT with an anti-a-smooth muscle actin-Cy3 (SMA-Cy3,
C6198, Sigma, 1:200) antibody, a secondary antibody (A-21245,
goat anti-rabbit Alexa Fluor 647, Invitrogen), and nucleic acid stain
Hoechst 33342 (B2261, Sigma), and mounted in Fluoromount G
imaging medium (00-4958-02, Affymetrix eBioscience).
For paraffin-embedded specimens (embryo, aortic arch, thoracic
aorta, aortic root, kidney, duodenum, jejunum, ileum, and colon),
4-lM sections were prepared. For immunofluorescence, antigen
retrieval was performed with 10 mM sodium citrate buffer (pH 6).
Samples were blocked for 1 h at RT with 5% BSA and 5% normal
goat serum in PBS. Sections were incubated overnight at 4°C with
anti-BiP (3177, Cell Signaling, 1:100), anti-PDI (3501, Cell Signaling,
1:100), anti-calreticulin (ab92516, abcam, 1:250), anti-lamin A/
progerin (sc-20680, Santa Cruz Biotechnology, 1:100), and anti-
CD31 (DIA-310, Dianova, 1:50) antibodies diluted in PBS containing
2.5% normal goat serum. Sections were incubated for 2 h at RT
with an anti-SMA-Cy3 antibody (C6198, Sigma, 1:200), secondary
antibodies (A-21245, goat anti-rabbit Alexa Fluor 647, Invitrogen,
and A-11006, goat anti-rat Alexa Fluor 488, Invitrogen), and/or
Hoechst 33342 stain (B2261, Sigma) diluted in 2.5% normal goat
serum in PBS, and mounted using Fluoromount G imaging medium.
H&E-stained sections were scanned using a NanoZoomer-RS
scanner (Hamamatsu), and images were exported with NDP.view2.
Fluorescence images were acquired with a Zeiss LSM 700 confocal
microscope. Image analysis was performed using ImageJ Fiji soft-
ware by a researcher blinded to genotype. Smooth muscle content
(as % of SMA-positive area) in the muscularis externa of the intes-
tine was quantified in one section of duodenum, jejunum, ileum,
and colon per animal. Aorta and plaque features were analyzed in
approximately 3 sections (for aortic arch and aortic root) and/or 4
(for thoracic aorta) per animal, and the mean was used for the
statistical analysis.
Statistical analysis
Kolmogorov–Smirnov and D’Agostino-Pearson normality tests were
used to evaluate data distribution. For parametric data, a t-test was
used to compare two groups (two-sample t-test) or one group to a
hypothetical value (one-sample t-test). Statistical tests were one- or
two-tailed depending on the previous hypothesis (e.g., one-tailed
t-test was used for RNAseq data validation experiments). For two
groups with unequal variances, a Welch’s correction was applied.
To compare multiple groups, a one-way ANOVA with Tukey’s post
hoc test was used, as this approach is resistant to normality viola-
tions and unequal variances with similar-sized groups. For Kaplan–
Meier survival curves, a log-rank (Mantel-Cox) test was applied.
Data were represented as mean (SEM). Outliers were evaluated
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using GraphPad outlier calculator (www.graphpad.com/quickcalcs/
Grubbs1.cfm). GraphPad Prism 5 was used for statistical analysis.
Differences were considered significant at P < 0.05.
Data Availability
RNA sequencing data were deposited in the NCBI SRA, accession
number: SRP099105 (https://www.ncbi.nlm.nih.gov/sra/?term=
SRP099105). Other data that support the findings of this study are
available from the corresponding authors upon request.
Expanded View for this article is available online.
Acknowledgements
We thank Simon Bartlett for English editing, the CNIC Genomics and Bioinfor-
matics Units for RNAseq studies and support with RNAseq data analysis, and
Eva Santos, Virginia Zorita, and the CNIC Animal Facility for animal care. Work
in VA’s laboratory is supported by grants from the Spanish Instituto de Salud
Carlos III (RD12/0042/0028, AC17/00067 and AC16/00091) and Ministerio de
Ciencia, Innovación y Universidades (MCIU) (SAF2016-79490-R), with co-
funding from the Fondo Europeo de Desarrollo Regional (FEDER, “Una manera
de hacer Europa”), the Progeria Research Foundation (Established Investigator
Award 2014-52), and the Fundació Marató TV3 (122/C/2015). The CNIC is
supported by the MCIU and the Pro CNIC Foundation, and is a Severo Ochoa
Center of Excellence (SEV-2015-0505). Work in the Lopez-Otin laboratory is
supported by grants from the Ministerio de Economía y Competitividad
(MINECO/FEDER), the European Research Council, and the Progeria Research
Foundation. The Instituto Universitario de Oncología is supported by Obra
Social Cajastur. Work in the Misteli laboratory was supported by the Intramu-
ral Research Program of the National Institutes of Health, National Cancer
Institute, and Center for Cancer Research. The MCIU supported RVB (“Juan de
la Cierva” JCI-2011-09663 and SAF-2014-60699-JIN postdoctoral contracts) and
MRH (FPI predoctoral contract BES-2011-043938 and “Juan de la Cierva” FJCI-
2017-33299 postdoctoral contract). RMN is supported by the Ministerio de
Educación, Cultura y Deporte (FPU predoctoral contract FPU16/05027). VQ is
supported by grants from the Principado de Asturias and MINECO, including
FEDER funding. SV was supported by an Erwin Schroedinger Fellowship from
the Austrian Science Fund (J3849-B28).
Author contributions
MRH designed and performed experiments, analyzed data, and prepared
figures and the manuscript. RV-B supervised research and project planning,
designed and performed experiments, and analyzed data. VQ, PG, SV, RMN,
and MJA-M performed experiments and analyzed data. TM provided advice on
the design, supervision, and analysis of experiments. CL-O supervised project
planning and data interpretation. VA supervised the research, project planning,
and data interpretation and prepared the manuscript. All authors read and
approved the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
For more information
(i) Progeria Research Foundation: www.progeriaresearch.org
(ii) Hutchinson–Gilford progeria syndrome: www.omim.org/entry/176670
(iii) Lamin A/C: www.omim.org/entry/150330
References
Andrews S (2010) FastQC: a quality control tool for high throughput
sequence data.
Angelico M, Tisone G, Baiocchi L, Palmieri G, Pisani F, Negrini S, Anselmo A,
Vennarecci G, Casciani CU (1999) One-year pilot study on
tauroursodeoxycholic acid as an adjuvant treatment after liver
transplantation. Ital J Gastroenterol Hepatol 31: 462 – 468
Bentayeb K, Batlle R, Sanchez C, Nerin C, Domeno C (2008) Determination of
bile acids in human serum by on-line restricted access material-ultra
high-performance liquid chromatography-mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci 869: 1 – 8
Burlina AB, Ogier H, Korall H, Trefz FK (2001) Long-term treatment with
sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.
Mol Genet Metab 72: 351 – 355
Cai Z, Li F, Gong W, Liu W, Duan Q, Chen C, Ni L, Xia Y, Cianflone K, Dong N et al
(2013) Endoplasmic reticulum stress participates in aortic valve calcification
in hypercholesterolemic animals. Arterioscler Thromb Vasc Biol 33: 2345 – 2354
Crosignani A, Battezzati PM, Setchell KD, Invernizzi P, Covini G, Zuin M,
Podda M (1996) Tauroursodeoxycholic acid for treatment of primary
biliary cirrhosis. A dose-response study. Dig Dis Sci 41: 809 – 815
Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA (2003) Nrf2
is a direct PERK substrate and effector of PERK-dependent cell survival.
Mol Cell Biol 23: 7198 – 7209
The paper explained
Problem
Hutchinson–Gilford progeria syndrome (HGPS) is a premature aging
syndrome caused by expression of an aberrant protein called progerin.
Patients present accelerated atherosclerosis and die from myocardial
infarction or stoke in their teens, despite having normal serum choles-
terol levels. One of the most striking characteristics of HGPS is the
massive loss of vascular smooth muscle cells (VSMC) in the vessel
wall. However, the mechanisms leading to progerin-driven VSMC
death remain largely unexplored. Furthermore, there is no effective
treatment targeting progerin-induced atherosclerosis, the death-
causing symptom in HGPS.
Results
High-throughput transcriptomic analysis of pre-disease medial aortas
from ubiquitous and VSMC-specific progeroid mice identified endo-
plasmic reticulum (ER) stress and the subsequent unfolded protein
response (UPR) as possible drivers of VSMC death. Activation of this
pathway was also detected in HGPS patient-derived cells. Treatment
with tauroursodeoxycholic acid (TUDCA), a chemical chaperone that
increases the ability of a cell to tolerate ER stress, delayed VSMC loss
and inhibited atherosclerotic plaque formation in the aorta of both
progeroid models fed high-fat diet. Moreover, TUDCA prolonged
survival in the normal chow-fed VSMC-specific progeroid model.
Impact
This study identifies ER stress and the UPR as a novel pathway in the
etiopathology of HGPS, especially in relation to VSMCs. The study
furthermore proposes the use of TUDCA to treat progerin-induced
vascular disease. Because progerin has been found at low levels in
cells and tissues from normally aging individuals, the results of the
present study may also be relevant to research on physiological aging
and associated cardiovascular disease. Moreover, our findings may
shed light on other diseases involving VSMC death.
ª 2019 The Authors EMBO Molecular Medicine 11: e9736 | 2019 11 of 13
Magda R Hamczyk et al Endoplasmic reticulum stress in progeria EMBO Molecular Medicine
Published online: March 12, 2019 
De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J,
Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M et al
(2003) Lamin a truncation in Hutchinson–Gilford progeria. Science
300: 2055
Dorado B, Andres V (2017) A-type lamins and cardiovascular disease in
premature aging syndromes. Curr Opin Cell Biol 46: 17 – 25
Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR,
Robbins CM, Moses TY, Berglund P et al (2003) Recurrent de novo point
mutations in lamin A cause Hutchinson–Gilford progeria syndrome.
Nature 423: 293 – 298
Fernandez P, Scaffidi P, Markert E, Lee JH, Rane S, Misteli T (2014)
Transformation resistance in a premature aging disorder identifies a
tumor-protective function of BRD4. Cell Rep 9: 248 – 260
Gavin J, Quilty F, Majer F, Gilsenan G, Byrne AM, Long A, Radics G, Gilmer JF
(2016) A fluorescent analogue of tauroursodeoxycholic acid reduces ER
stress and is cytoprotective. Bioorg Med Chem Lett 26: 5369 – 5372
Gordon LB, Harten IA, Patti ME, Lichtenstein AH (2005) Reduced adiponectin
and HDL cholesterol without elevated C-reactive protein: clues to the
biology of premature atherosclerosis in Hutchinson–Gilford Progeria
Syndrome. J Pediatr 146: 336 – 341
Gordon LB, McCarten KM, Giobbie-Hurder A, Machan JT, Campbell SE, Berns
SD, Kieran MW (2007) Disease progression in Hutchinson–Gilford
progeria syndrome: impact on growth and development. Pediatrics 120:
824 – 833
Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-
Herman M, Smoot LB, Gordon CM, Cleveland R, Snyder BD et al (2012)
Clinical trial of a farnesyltransferase inhibitor in children with
Hutchinson–Gilford progeria syndrome. Proc Natl Acad Sci USA 109:
16666 – 16671
Gordon LB, Massaro J, D’Agostino RB Sr, Campbell SE, Brazier J, Brown WT,
Kleinman ME, Kieran MW, Progeria Clinical Trials C (2014a) Impact of
farnesylation inhibitors on survival in Hutchinson–Gilford progeria
syndrome. Circulation 130: 27 – 34
Gordon LB, Rothman FG, Lopez-Otin C, Misteli T (2014b) Progeria: a
paradigm for translational medicine. Cell 156: 400 – 407
Gordon LB, Kleinman ME, Massaro J, D’Agostino RB Sr, Shappell H, Gerhard-
Herman M, Smoot LB, Gordon CM, Cleveland RH, Nazarian A et al (2016)
Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin,
and zoledronic acid in children with Hutchinson–Gilford progeria
syndrome. Circulation 134: 114 – 125
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg
RA (1999) Creation of human tumour cells with defined genetic elements.
Nature 400: 464 – 468
Hamczyk MR, del Campo L, Andres V (2018a) Aging in the cardiovascular
system: lessons from Hutchinson–Gilford progeria syndrome. Annu Rev
Physiol 80: 27 – 48
Hamczyk MR, Villa-Bellosta R, Gonzalo P, Andres-Manzano MJ, Nogales P,
Bentzon JF, Lopez-Otin C, Andres V (2018b) Vascular smooth muscle-
specific progerin expression accelerates atherosclerosis and death in a
mouse model of Hutchinson–Gilford progeria syndrome. Circulation 138:
266 – 282
Hanumanthappa NB, Madhusudan G, Mahimarangaiah J, Manjunath CN
(2011) Hutchinson–Gilford progeria syndrome with severe calcific aortic
valve stenosis. Ann Pediatr Cardiol 4: 204 – 206
Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN,
Michieletti P, Minuk GY, Pappas SC, Scully LJ et al (1994) The Canadian
Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic
acid in primary biliary cirrhosis. Hepatology 19: 1149 – 1156
Hennekam RC (2006) Hutchinson–Gilford progeria syndrome: review of the
phenotype. Am J Med Genet A 140: 2603 – 2624
Hulsen T, de Vlieg J, Alkema W (2008) BioVenn - a web application for the
comparison and visualization of biological lists using area-proportional
Venn diagrams. BMC Genom 9: 488
Invernizzi P, Setchell KD, Crosignani A, Battezzati PM, Larghi A, O’Connell NC,
Podda M (1999) Differences in the metabolism and disposition of
ursodeoxycholic acid and of its taurine-conjugated species in patients
with primary biliary cirrhosis. Hepatology 29: 320 – 327
Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, Patterson
BW, Horton JD, Mittendorfer B, Hotamisligil GS et al (2010)
Tauroursodeoxycholic Acid may improve liver and muscle but not adipose
tissue insulin sensitivity in obese men and women. Diabetes 59:
1899 – 1905
Kreienkamp R, Billon C, Bedia-Diaz G, Albert CJ, Toth Z, Butler AA, McBride-
Gagyi S, Ford DA, Baldan A, Burris TP et al (2018) Doubled lifespan and
patient-like pathologies in progeria mice fed high-fat diet. Aging Cell 18:
e12852
Kubben N, Zhang W, Wang L, Voss TC, Yang J, Qu J, Liu GH, Misteli T (2016)
Repression of the antioxidant NRF2 pathway in premature aging. Cell 165:
1361 – 1374
Larghi A, Crosignani A, Battezzati PM, De Valle G, Allocca M, Invernizzi P,
Zuin M, Podda M (1997) Ursodeoxycholic and tauro-ursodeoxycholic acids
for the treatment of primary biliary cirrhosis: a pilot crossover study.
Aliment Pharmacol Ther 11: 409 – 414
Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-
Seq data with or without a reference genome. BMC Bioinformatics 12: 323
Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA,
Harrison JM, Wiesner RH, Anderson ML, Lange SM et al (1994)
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
Gastroenterology 106: 1284 – 1290
Liu B, Wang Z, Ghosh S, Zhou Z (2013) Defective ATM-Kap-1-mediated
chromatin remodeling impairs DNA repair and accelerates senescence in
progeria mouse model. Aging Cell 12: 316 – 318
Lopez-Mejia IC, de Toledo M, Chavey C, Lapasset L, Cavelier P, Lopez-Herrera
C, Chebli K, Fort P, Beranger G, Fajas L et al (2014) Antagonistic functions
of LMNA isoforms in energy expenditure and lifespan. EMBO Rep 15:
529 – 539
Maestri NE, Brusilow SW, Clissold DB, Bassett SS (1996) Long-term treatment
of girls with ornithine transcarbamylase deficiency. N Engl J Med 335:
855 – 859
Marino G, Ugalde AP, Salvador-Montoliu N, Varela I, Quiros PM, Cadinanos J,
van der Pluijm I, Freije JM, Lopez-Otin C (2008) Premature aging in mice
activates a systemic metabolic response involving autophagy induction.
Hum Mol Genet 17: 2196 – 2211
Martin M (2011) Cutadapt removes adapter sequences from high-throughput
sequencing reads. 2011 17
Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer
CC, Zalewski C, Kim HJ, Solomon B et al (2008) Phenotype and course of
Hutchinson–Gilford progeria syndrome. N Engl J Med 358: 592 – 604
Mlynarczyk C, Fahraeus R (2014) Endoplasmic reticulum stress sensitizes
cells to DNA damage-induced apoptosis through p53-dependent
suppression of p21(CDKN1A). Nat Commun 5: 5067
Nair K, Ramachandran P, Krishnamoorthy KM, Dora S, Achuthan TJ (2004)
Hutchinson–Gilford progeria syndrome with severe calcific aortic valve
stenosis and calcific mitral valve. J Heart Valve Dis 13: 866 – 869
Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, Erdos MR, Blair C,
Funke B, Smoot L et al (2010) Cardiovascular pathology in Hutchinson–
12 of 13 EMBO Molecular Medicine 11: e9736 | 2019 ª 2019 The Authors
EMBO Molecular Medicine Endoplasmic reticulum stress in progeria Magda R Hamczyk et al
Published online: March 12, 2019 
Gilford progeria: correlation with the vascular pathology of aging.
Arterioscler Thromb Vasc Biol 30: 2301 – 2309
Osorio FG, Navarro CL, Cadinanos J, Lopez-Mejia IC, Quiros PM, Bartoli C,
Rivera J, Tazi J, Guzman G, Varela I et al (2011) Splicing-directed therapy
in a new mouse model of human accelerated aging. Sci Transl Med 3:
106ra107
Osorio FG, Barcena C, Soria-Valles C, Ramsay AJ, de Carlos F, Cobo J, Fueyo A,
Freije JM, Lopez-Otin C (2012) Nuclear lamina defects cause ATM-
dependent NF-kappaB activation and link accelerated aging to a systemic
inflammatory response. Genes Dev 26: 2311 – 2324
Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Gorgun
CZ, Hotamisligil GS (2006) Chemical chaperones reduce ER stress and
restore glucose homeostasis in a mouse model of type 2 diabetes. Science
313: 1137 – 1140
Poupon RE, Bonnand AM, Chretien Y, Poupon R (1999) Ten-year survival in
ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The
UDCA-PBC Study Group. Hepatology 29: 1668 – 1671
Prakash A, Gordon LB, Kleinman ME, Gurary EB, Massaro J, D’Agostino R Sr,
Kieran MW, Gerhard-Herman M, Smoot L (2018) Cardiac abnormalities in
patients with Hutchinson–Gilford progeria syndrome. JAMA Cardiol 3:
326 – 334
Rani S, Sreenivasaiah PK, Kim JO, Lee MY, Kang WS, Kim YS, Ahn Y, Park WJ,
Cho C, Kim DH (2017) Tauroursodeoxycholic acid (TUDCA) attenuates
pressure overload-induced cardiac remodeling by reducing endoplasmic
reticulum stress. PLoS One 12: e0176071
Rivard AL, Steer CJ, Kren BT, Rodrigues CM, Castro RE, Bianco RW, Low WC
(2007) Administration of tauroursodeoxycholic acid (TUDCA) reduces
apoptosis following myocardial infarction in rat. Am J Chin Med 35:
279 – 295
Rivera-Torres J, Acin-Perez R, Cabezas-Sanchez P, Osorio FG, Gonzalez-Gomez
C, Megias D, Camara C, Lopez-Otin C, Enriquez JA, Luque-Garcia JL et al
(2013) Identification of mitochondrial dysfunction in Hutchinson–Gilford
progeria syndrome through use of stable isotope labeling with amino
acids in cell culture. J Proteomics 91: 466 – 477
Rivera-Torres J, Calvo CJ, Llach A, Guzman-Martinez G, Caballero R, Gonzalez-
Gomez C, Jimenez-Borreguero LJ, Guadix JA, Osorio FG, Lopez-Otin C et al
(2016) Cardiac electrical defects in progeroid mice and Hutchinson–Gilford
progeria syndrome patients with nuclear lamina alterations. Proc Natl
Acad Sci USA 113: E7250 – E7259
Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package
for differential expression analysis of digital gene expression data.
Bioinformatics 26: 139 – 140
Scaffidi P, Misteli T (2011) In vitro generation of human cells with cancer
stem cell properties. Nat Cell Biol 13: 1051 – 1061
Senft D, Ronai ZA (2015) UPR, autophagy, and mitochondria crosstalk
underlies the ER stress response. Trends Biochem Sci 40: 141 – 148
Setchell KD, Rodrigues CM, Podda M, Crosignani A (1996) Metabolism of
orally administered tauroursodeoxycholic acid in patients with primary
biliary cirrhosis. Gut 38: 439 – 446
Stehbens WE, Wakefield SJ, Gilbert-Barness E, Olson RE, Ackerman J (1999)
Histological and ultrastructural features of atherosclerosis in progeria.
Cardiovasc Pathol 8: 29 – 39
Stehbens WE, Delahunt B, Shozawa T, Gilbert-Barness E (2001) Smooth
muscle cell depletion and collagen types in progeric arteries. Cardiovasc
Pathol 10: 133 – 136
Strandgren C, Revechon G, Sola-Carvajal A, Eriksson M (2017) Emerging
candidate treatment strategies for Hutchinson–Gilford progeria syndrome.
Biochem Soc Trans 45: 1279 – 1293
Swift J, Ivanovska IL, Buxboim A, Harada T, Dingal PC, Pinter J, Pajerowski JD,
Spinler KR, Shin JW, Tewari M et al (2013) Nuclear lamin-A scales with
tissue stiffness and enhances matrix-directed differentiation. Science 341:
1240104
Swift J, Discher DE (2014) The nuclear lamina is mechano-responsive to ECM
elasticity in mature tissue. J Cell Sci 127: 3005 – 3015
Ullrich NJ, Gordon LB (2015) Hutchinson–Gilford progeria syndrome. Handb
Clin Neurol 132: 249 – 264
Uppala JK, Gani AR, Ramaiah KVA (2017) Chemical chaperone, TUDCA unlike
PBA, mitigates protein aggregation efficiently and resists ER and non-ER
stress induced HepG2 cell death. Sci Rep 7: 3831
Vidak S, Foisner R (2016) Molecular insights into the premature aging disease
progeria. Histochem Cell Biol 145: 401 – 417
Villa-Bellosta R, Rivera-Torres J, Osorio FG, Acin-Perez R, Enriquez JA, Lopez-
Otin C, Andres V (2013) Defective extracellular pyrophosphate metabolism
promotes vascular calcification in a mouse model of Hutchinson–Gilford
progeria syndrome that is ameliorated on pyrophosphate treatment.
Circulation 127: 2442 – 2451
Villa-Bellosta R, Hamczyk MR, Andres V (2017) Novel phosphate-activated
macrophages prevent ectopic calcification by increasing extracellular ATP
and pyrophosphate. PLoS One 12: e0174998
Xie Q, Khaoustov VI, Chung CC, Sohn J, Krishnan B, Lewis DE, Yoffe B (2002)
Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-
induced caspase-12 activation. Hepatology 36: 592 – 601
Yang SH, Qiao X, Farber E, Chang SY, Fong LG, Young SG (2008) Eliminating the
synthesis of mature lamin A reduces disease phenotypes in mice carrying a
Hutchinson–Gilford progeria syndrome allele. J Biol Chem 283: 7094 – 7099
Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R,
Zhang Y, Tse HF et al (2011) A human iPSC model of Hutchinson Gilford
Progeria reveals vascular smooth muscle and mesenchymal stem cell
defects. Cell Stem Cell 8: 31 – 45
Zhang H, Xiong ZM, Cao K (2014) Mechanisms controlling the smooth
muscle cell death in progeria via down-regulation of poly(ADP-ribose)
polymerase 1. Proc Natl Acad Sci USA 111: E2261 – E2270
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
ª 2019 The Authors EMBO Molecular Medicine 11: e9736 | 2019 13 of 13
Magda R Hamczyk et al Endoplasmic reticulum stress in progeria EMBO Molecular Medicine
Published online: March 12, 2019 
